IL18 and Parkinson disease: In PD rats, kaempferol has been reported to reduce the loss of tyrosine hydroxylase (TH)-positive neurons, improve motor dysfunction, inhibit microglial activation, and downregulate the levels of inflammatory factors IL-18 and IL-1β (Cai et al. 2022; Jin et al. 2023).